Status:
TERMINATED
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)
Lead Sponsor:
Johns Hopkins University
Conditions:
Infertility
Eligibility:
FEMALE
21-37 years
Phase:
NA
Brief Summary
Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of...
Eligibility Criteria
Inclusion
- Age 21-37
- Female
- Less than two previous unsuccessful IVF cycles
Exclusion
- Day 3 FSH \>9.9
- Fewer than 8 mature oocytes retrieved
- Fewer than 8 normally fertilized embryos on day 2 after fertilization
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00788619
Start Date
January 1 2009
End Date
October 1 2009
Last Update
December 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Fertility Center
Lutherville, Maryland, United States, 21093